Your nose knows how to target brain inflammation

por Winger, Ryan C., Zamvil, Scott S.
Publicado 2016

Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration

por Watson, Richard L., Buck, Jochen, Levin, Lonny R., Winger, Ryan C., Wang, Jing, Arase, Hisashi, Muller, William A.
Publicado 2015

CNS accumulation of regulatory B cells is VLA-4-dependent

por Lehmann-Horn, Klaus, Sagan, Sharon A., Winger, Ryan C., Spencer, Collin M., Bernard, Claude C.A., Sobel, Raymond A., Zamvil, Scott S.
Publicado 2016

T-bet is essential for encephalitogenicity of both Th1 and Th17 cells

por Yang, Yuhong, Weiner, Jeffrey, Liu, Yue, Smith, Alan J., Huss, David J., Winger, Ryan, Peng, Haiyan, Cravens, Petra D., Racke, Michael K., Lovett-Racke, Amy E.
Publicado 2009

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod

por Cohen, Jeffrey A, Bar-Or, Amit, Cree, Bruce A C, Mao-Draayer, Yang, Han, May H, Singer, Barry, Jannu, Ann, Kolodny, Scott, Meng, Xiangyi, Winger, Ryan C
Publicado 2019

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis

por Barrera, Britney, Simpson, Haley, Engebretson, Eric, Sillau, Stefan, Valdez, Brooke, Parra‐González, José, Winger, Ryan C., Epperson, Lou Anne, Banks, Ashley, Pierce, Kathryn, Spotts, Melanie, O'Gean, Katie, Alvarez, Enrique, Gross, Robert, Piquet, Amanda L., Schreiner, Teri, Corboy, John R., Pei, Jinglan, Vollmer, Timothy L., Nair, Kavita V.
Publicado 2023

Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies

por Kister, Ilya, Curtin, Ryan, Pei, Jinglan, Perdomo, Katherine, Bacon, Tamar E., Voloshyna, Iryna, Kim, Joseph, Tardio, Ethan, Velmurugu, Yogambigai, Nyovanie, Samantha, Valeria Calderon, Andrea, Dibba, Fatoumatta, Stanzin, Igda, Samanovic, Marie I., Raut, Pranil, Raposo, Catarina, Priest, Jessica, Cabatingan, Mark, Winger, Ryan C., Mulligan, Mark J., Patskovsky, Yury, Silverman, Gregg J., Krogsgaard, Michelle
Publicado 2022

Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study...

por Kister, Ilya, Patskovsky, Yury, Curtin, Ryan, Pei, Jinglan, Perdomo, Katherine, Rimler, Zoe, Voloshyna, Iryna, Samanovic, Marie I., Cornelius, Amber R., Velmurugu, Yogambigai, Nyovanie, Samantha, Kim, Joseph J., Tardio, Ethan, Bacon, Tamar E., Zhovtis Ryerson, Lana, Raut, Pranil, Pedotti, Rosetta, Hawker, Kathleen, Raposo, Catarina, Priest, Jessica, Cabatingan, Mark, Winger, Ryan C., Mulligan, Mark J., Krogsgaard, Michelle, Silverman, Gregg J.
Publicado 2022

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

por Shinoda, Koji, Li, Rui, Rezk, Ayman, Mexhitaj, Ina, Patterson, Kristina R., Kakara, Mihir, Zuroff, Leah, Bennett, Jeffrey L., von Büdingen, H.-Christian, Carruthers, Robert, Edwards, Keith R., Fallis, Robert, Giacomini, Paul S., Greenberg, Benjamin M., Hafler, David A., Ionete, Carolina, Kaunzner, Ulrike W., Lock, Christopher B., Longbrake, Erin E., Pardo, Gabriel, Piehl, Fredrik, Weber, Martin S., Ziemssen, Tjalf, Jacobs, Dina, Gelfand, Jeffrey M., Cross, Anne H., Cameron, Briana, Musch, Bruno, Winger, Ryan C., Jia, Xiaoming, Harp, Christopher T., Herman, Ann, Bar-Or, Amit
Publicado 2023